Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.810
-0.100 (-2.04%)
Apr 16, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $9.24 million as of April 17, 2026. Its market cap has decreased by -39.73% in one year.
Market Cap
9.24M
Enterprise Value
4.70M
1-Year Change
-39.73%
Ranking
Category
Stock Price
$4.81
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $9.24M, a decrease of -98.66%. That is a compound annual growth rate of -56.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 9.43M | -10.11% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 10.80M |
| BioVie | 10.63M |
| Evogene | 10.24M |
| CalciMedica | 10.00M |
| Traws Pharma | 9.83M |
| NuCana | 9.07M |
| Acurx Pharmaceuticals | 8.85M |
| Creative Medical Technology Holdings | 8.58M |